Skip to content

Multicenter, retrospective study of clinical features and long-term prognosis in patients with brucellosis

Multicenter, retrospective study of clinical features and long-term prognosis in patients with brucellosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068766
Enrollment
Unknown
Registered
2023-02-28
Start date
2022-04-27
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brucellosis

Interventions

case series:Nil

Sponsors

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age or gender are not limited; 2. Patients discharged from the hospital with a diagnosis of brucellosis; 3. Specifically refer to the People's Republic of China health industry standard "Brucellosis Diagnosis" (WS269-2019) to confirm the diagnosis of brucellosis patients, that is, the patient meets the suspected or clinically diagnosed cases and at the same time passes any of the confirmed tests mentioned below to confirm: a) Isolation of Brucella from cultures of any pathological material such as the patient's blood, bone marrow, other body fluids, and excreta. b) The IVF test (SAT) has titers of 1:100++ and above, or 1:50++ and above in patients with a duration of more than one year and still have clinical symptoms. c) Complement binding test (CFT) titer of 1:10++ and above. d) Anti-human immunoglobulin test (Coomb's) titer of 1:400++ and above. 4. Voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1. History of severe lumbar spine trauma before the diagnosis of brucellosis; 2. Have undergone lumbosacral spine surgery before being diagnosed with brucellosis; 3. Scoliosis; 4. Currently participating in clinical trials of other drugs or medical devices; The investigators did not consider it suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Clinical features (Time frame: 2 years);Incidence of complications;

Secondary

MeasureTime frame
survival rate;disease outcome (well, better, not cured, progression, recurrence and death) ;etiology characteristics (sheep subtype [1, 2, 3], cattle [1-9 subtypes], pig subtype [1-5], breed);Number of patients with severe brucellosis (ICU);antibacterial treatment;Hospitalization expenses;

Countries

China

Contacts

Public ContactQing ning

Tongji Hospital Medical Ethics Committee affiliated to Tongji Medical College of Huazhong University of Science & Technology

qning@vip.sina.com13971521450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026